methylen blue
News
14.03.2016
Merck Initiates Phase III Study of MSB11022
Merck, a leading science and technology company, today announced the initiation of a global Phase III clinical study of MSB11022, a proposed biosimilar of adalimumab, in chronic plaque psoriasis. This […]
13.07.2016
Cynosure to Ring NASDAQ Stock Market Closing Bell to Celebrate 25 Year Anniversary
Cynosure, Inc. (NASDAQ: CYNO) today announced that President and CEO Michael Davin, along with other members of the Company’s management team, will ring the Closing Bell at the NASDAQ Stock […]
31.05.2018
Cutera Announces Opening of New Office and Training Center in Madrid
CUTERA, INC., (Nasdaq:CUTR) (“Cutera” or the “Company”) a leading provider of laser, light and other energy-based aesthetic systems for practitioners worldwide, announces the opening of its new office and training […]